Case Study Neubau einer Parenteralia Fabrik 3. GMP-Forum, Kirchzarten 28. September 2012, Basel. Philip Schneider, F.



Similar documents
GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

ISOLATOR TECHNOLOGY MANUFACTURING

VALIDATION OF ASEPTIC PROCESSES

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online.

All Processes Dr. Paul Ruffieux Consultant

Decontamination and Waste Management

Overcoming Challenges in the Manufacturing of Pre-Filled Syringes. Farvea, a new comer in the PFS world PFS Tech June 2016 pharma@fareva.

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Sterile operation scenarios at GSK-Parma

Regulations Concerning

Basic Requirements For Aseptic Manufacturing Of Sterile Medicinal Products A Comparison Between Europe And USA

Top 10 considerations when validating an autoclave

2016 > Emcure Pharmaceuticals Limited 3/3/16

EU GMP Annex 1 Update 2008: Airborne Particle Counting

Cleanroom. For. Sterile Manufacturing Facilities

Washing. Sterilising. Filling. Closing. Inspecting. Labelling

Steam Sterilization and the 2007 Revision of PDA Technical Report 1

The Perfect Partnership for GMP Cleaning Services. Total Cleaning Solutions from Micronclean & Isocleanse

FILLING, STOPPERING AND CAPPING MACHINES

White Paper. The Gap Between LIMS Capabilities and Environmental Monitoring Needs. Abstract. The Environmental Monitoring Workflow

BEHAVIOUR EXPERIENCE MEDIA FILL QUALIFICATION TRAINING MONITORING GOWNING PERSONAL ATTRIBUTES QUALIFICATION

How To Store An Acam2000 Vaccine

Particle Monitoring Requirements in Pharmaceutical Cleanrooms

MHRA Questions and Answers for Specials manufacturer s

Aseptic preparations, including TPN, for a limited number of patients

Federal Wage System Job Grading Standard For Laboratory Working, Table of Contents

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI

Cleaning validation of cleanrooms and preparation equipments

Qualification of an Environmental Monitoring Program

On-Site GMP Training GMP COMPLIANCE TECHNICAL

Hazardous Drugs Compounded by a Prescriber.

ENVIRONMENTAL MONITORING

German engineering under high pressure

WHITE PAPER April 18, 2016

Guidance on safe use of Autoclaves

HSL-VS Vials + Syringes

Sterile and Ready-to-fill Glass Containers with new Packaging and Connection Solutions

Recommendations for the Safe Use of Handling of Cytotoxic Drugs

Environmental Monitoring of Clean Rooms

University of Toronto Office of Environmental Health and Safety Biosafety Containment Level 3

Autoclave Safety. Autoclaves are sterilizers using high pressure and high temperature steam. The potential safety risks for the operators are:

Cleaning. By the end of this chapter, you will be able to: Introduction. Definitions. Chapter 9

Biotechpharma company profile

Open Microphone Meeting:

Hazard Analysis and Critical Control Points (HACCP) 1 Overview

Precision injection moulding

Environmental Monitoring Risk Assessment

Improving Uptime in Aseptic Processing of Pharmaceutical Liquids with Blow-Fill-Seal

The use of risk assessment tools for microbiological assessment of cleanroom environments. by Tim Sandle

How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs

On-Site GMP Training GMP COMPLIANCE TECHNICAL

Bench Autoclave. Standard Operating Procedure. For Installation, Use and Maintenance

Safety. matters. CryoMACS Products

Cleaning and Contamination Control

Barrier and isolation systems

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

USP Guidances on Environmental Control including related USP, FDA, EMEA & PDA Activities. James Agalloco Agalloco & Associates

Environmental Monitoring

Liquids Suspensions Gels

STANDARD OPERATING PROCEDURES SPILL RESPONSE AND CLEAN-UP OUTSIDE BIOSAFETY CABINET

Pharmagraph. GMP/GLP Monitoring System

Design, Operation and Management of GTP/GMP Cell Engineering Facilities

I-140 Venipuncture for Blood Specimen Collection

Production/Machine Operator Life Sciences CURRICULUM/SYLLABUS

Officer Incharge: (Checked by)

Assessing Filling Technologies For Contamination Risk

Annex 2 WHO good practices for pharmaceutical microbiology laboratories

Free Examples of plant layout drawing

Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates

Risk Based Environmental Monitoring (EM) and EM Data Management and Trending

GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS

Revision 5. Calvin College Medical Waste Management Plan. Date: Health and Safety

Qualifying Visual Inspectors - The benchmarking process. Markus Lankers, PhD Rap.ID Particle Systems GmbH December 2014

Isolation of Caffeine from Tea

STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA

FDA and the Compounding Pharmacy

Microbiology and Auditing. Don Singer

Astellas Ireland Company Ltd. (Kerry Plant) Ampoule Inspection Machine. Eoin O Sullivan 5th June 2014

Economical Approaches to Meeting Global Demand for High Value Biopharmaceuticals

Inova SV125 Machine Number

VACUETTE RNAgard Blood Tubes BioMaxi Blood RNA Purification Kit. For the collection, preservation and purification of RNA from whole blood

02.11 Food and Nutrition Services

ORGANIC SAMPLE PREPARATION

How Tight is a Syringe? PDA: A Global. CCI Case Studies From. Association. Development and Manufacturing. Dr. Derek Duncan Director Product Line

Combination Products. Presented by: Karen S. Ginsbury For: IFF March PCI Pharma

RE: Comments on USP 800 Hazardous Drugs Handling in Healthcare Settings

Dot Blot Analysis. Teacher s Guidebook. (Cat. # BE 502) think proteins! think G-Biosciences

A GUIDE TO AVA FOOD FACTORY GRADING SYSTEM

KGI MEDICAL WASTE MANAGEMENT PLAN

Steam Sterilization Cycles for Lab Applications

Arizona State University Institutional Animal Care and Use Committee STANDARD INSTITUTIONAL GUIDELINE RODENT SURGERY

Risk Management for Aseptic Processing

Understanding USP 797

INTRODUCING THE NEW. Xcelodose S. New Powder Micro-dosing System. Even Faster Time to First in Man

The Environmental Monitoring Program In a GMP Environment

SPILLS & SPILL KITS. Spills -General Guidelines:

7 Deadly Myths of USP 797 Webinar Q&A By Eric Kastango

Qualification of Cleanrooms and Environmental Monitoring - Practical Approaches in Europe

Transcription:

3. GMP-Forum, Kirchzarten 28. September 2012, Basel Philip Schneider, F. Hoffmann-La Roche

Content Introduction Decontamination cycle Set-up and change over Aseptic connections Glove handling and testing Interventions Media Fills

Content Introduction Decontamination cycle Set-up and change over Aseptic connections Glove handling and testing Interventions Media Fills

Introduction High Rack Warehouse NPK Bldg. 235 Bldg. 231 Final Packaging Bldg. 232 Liquid vials Compounding Pre-filled Syringes Lyophilization Materials in/out 4

Introduction GMP compliance and quality requirements of all countries/markets Use of existing infrastructure: High rack warehouse and AGV (Automated Guided Vehicles) Service building Modular concept No complete shutdown during annual maintenance Planned Maintenance of one module without affecting remaining modules Robust aseptic processes (Isolator or RABS) Product lead times of 3 to 5 days from compounding to warehouse (liquid products). Extension of lead time for lyo.-products depending on lyo-cycle time Paperless plant, Electronic Batch Recording 5

Introduction Lyophilization Pre Filled Syringes Compounding Liquid Vials 6

Introduction 2 nd Floor Technical floor: - HVAC - Electrical Class CNC Class D 1 st Floor 1 2 3 4 Production floor: 1. Vials lyophilized 2. Pre-filled syringes liquid 3. Compounding / Equipment cleaning 4. Vials liquid Class C Class A/B Support floor: Gowning, break room, offices, meeting rooms and laboratories Basement Support floor: Visual inspection, clean media generation and material in/out, cool storage stopper washing, thawing 7

Introduction Compounding Liquid Vials Perfilled syringes Lyophilised Vials Isolator 8

Introduction Liquid Vils Compounding Prefilled syringes 9

Introduction 10

Content Introduction Decontamination cycle Set-up and change over Aseptic connections Glove handling and testing Interventions Media Fills

Decontamination Cycle Process steps of a decontamination cycle 1. Pressure decay test of isolator 2. Dehumidification 3. VHP-cycle (Conditioning) 4. VHP-cycle (Decontamination) 5. Aeration VHP=Vaporized Hyrogen Peroxide

Experiences with Isolator Technology Decontamination Cycle Development Selection of materials within the isolator is important (i.e. silicone absorbs VHP, leading to long aeration times) Careful assessment of isolator loading prior decontamintation (the bigger the surface the longer the cycle) D-values of surface materials need to be known Development of cycle using bio-indicators (Geobacillus stearothermophillus)

Decontamination Cycle Determination of worst case areas for 6-log-reduction within the isolator (technical changes of the equipment might be necessary to enable VHPexposure)

Decontamination Cycle Validation/Re-validation Initial validation cycle with 3 consecutive runs Annual re-validation Re-validation in the event of changes (i.e. change in set-up loading of isolator)

Decontamination Cycle General aspects Decontamination Sterilisation (6-log-reduction for VHP-decontamination) A decontamination cycle takes time (change over!) Several conditions have impact to activity of VHP (i.e. temp. of surfaces) Sensitivity of materials, surfaces and product against VHP needs to be evaluated Covered surfaces during cycle need special attention

Content Introduction Decontamination cycle Set-up and change over Aseptic connections Glove handling and testing Interventions Media Fills

Set-up and change over Format change is not possible while isolator is closed (impact to line capacity in case of multi-format line) Format parts are installed prior VHP-decontamination while isolator is open (exposure to class D!) Measures to control bioburden prior VHP-decontamination is necessary (i.e. additional gowning requirements, cleaning of surfaces) Special measures necessary for equipment with product contact which is not sterilized in place (e.g. stopper bowl) Line clearance after test runs prior VHP-decontamination need special attention (i.e. in case of use of non-sterile rubber material)

Content Introduction Decontamination cycle Set-up and change over Aseptic connections Glove handling and testing Interventions Media Fills

Aseptic connections Zone C Laminar Flow SIP Dispensing & Compounding Zone D Sterilisation, Filling & Stoppering SIP Laminar Flow Zone A Filling & Stoppering Stoppers Material Transfer

Aseptic connections 21

Aseptic connections 22

Aseptic connections Hook-up to Isolator Hose connection 23

Content Introduction Decontamination cycle Set-up and change over Aseptic connections Glove handling and testing Interventions Media Fills

Glove handling and testing Common glove materials: Hypalon, PVC, Neopren (currently being tested at Roche s new lyo line in Kaiseraugst) Definition of frequency testing and changing of gloves required Glove testing Visual Pressure decade Definition of corrective measures in case of glove defect while filling (i.e. glove change, use of sterile tape)

Content Introduction Decontamination cycle Set-up and change over Aseptic connections Glove handling and testing Interventions Media Fills

Interventions Distinction of intervention (closed isolator) Routine intervention All intervention which are necessary during filling (i.e. collection monitoring plates) Non-Routine interventions All interventions which do no take place during filling (i.e. removing glass splinters after breakage) Limited access and space to solve all technical problems with interventions Detailed description of interventions in SOPs Training of intervention (a dummy isolator is helpful) Qualification operators by simulating interventions during media fills

Content Introduction Decontamination cycle Set-up and change over Aseptic connections Glove handling and testing Interventions Media Fills

Media Fills Initial aseptic validation of a new filling line by 3 consecutive media fills operators performing all routine interventions Annual media fills for Re-validation of filling line (typically after maintenance) Re-qualification of operator Performance of routine interventions and simulation of non-routine interventions Incubation at 25 C and 35 C for 7 days each; reading after each incubation temperature Experience so far: Approx. 15 media fills performed, no positive finding!

Pro & Contra Pro High level of sterility assurance during interventions Design of zone concept allows easy access to filling line w/o gowning Contra Time intense activities prior and post processing Limited flexibility in case of multi-format lines Not all technical issues can be solved via interventions at closed isolator

We Innovate Healthcare